Get Your Personalized Supplement StackSupplement Stack Quiz

Potassium Bisglycinate Chelate

Also known as: Potassium bisglycinate, Potassium glycinate chelate, Potassium amino acid chelate, Potassium bisglycinate chelate

Overview

Potassium bisglycinate chelate is a synthetic form of potassium supplement designed to enhance absorption and reduce gastrointestinal irritation compared to traditional inorganic potassium salts. In this compound, potassium ions are bound to two molecules of glycine, an amino acid, forming a chelate. This chelation mimics how minerals are naturally absorbed in the body, potentially leading to improved bioavailability. Its primary use is to increase potassium intake to support electrolyte balance, regulate blood pressure, maintain proper muscle function, and prevent hypokalemia (low potassium levels). While general potassium supplementation is extensively researched, direct clinical trials specifically on potassium bisglycinate chelate are limited. However, it is marketed for its potential benefits in cardiovascular and muscular health, leveraging the well-established benefits of potassium.

Benefits

Potassium supplementation, including forms like bisglycinate chelate, offers several evidence-based benefits. The most robust evidence supports its role in blood pressure regulation; meta-analyses consistently show that potassium supplementation can reduce systolic and diastolic blood pressure, particularly in individuals with hypertension. Reductions of approximately 3-5 mmHg in systolic BP are clinically significant for cardiovascular risk reduction. Furthermore, adequate potassium intake is associated with a reduced risk of stroke, with studies indicating a roughly 13% lower risk in those with higher intake. Secondary benefits include potential improvements in bone health by reducing urinary calcium loss, although this effect is more strongly linked to potassium citrate/bicarbonate. Potassium also helps regulate plasma aldosterone levels, which contributes to blood pressure control. These benefits are most pronounced in hypertensive and older adults, with effects typically observed after four weeks or more of consistent supplementation.

How it works

Potassium bisglycinate chelate delivers potassium, a crucial intracellular cation, to the body. Potassium plays a vital role in regulating vascular smooth muscle tone, influencing blood pressure. It is essential for the proper functioning of the sodium-potassium ATPase pump, which maintains cellular membrane potential and facilitates nerve impulse transmission and muscle contraction. Potassium also impacts renal sodium excretion, contributing to fluid balance and blood pressure control. Furthermore, it modulates aldosterone levels, a hormone that influences electrolyte balance. The chelation with glycine is hypothesized to enhance intestinal absorption by protecting the potassium ion from interactions with other dietary components and facilitating its transport across the intestinal wall, thereby improving bioavailability and reducing gastrointestinal side effects compared to non-chelated forms.

Side effects

Potassium bisglycinate chelate is generally considered safe when consumed within recommended dosages. Due to its chelated form, it tends to cause less gastrointestinal discomfort compared to inorganic potassium salts. However, mild gastrointestinal issues are still possible. The most significant risk associated with potassium supplementation is hyperkalemia (abnormally high potassium levels), which can be life-threatening and lead to severe cardiac arrhythmias. This risk is particularly elevated in individuals with pre-existing conditions such as renal impairment, Addison’s disease, or those taking certain medications that affect potassium levels. Caution is advised when combining potassium supplements with potassium-sparing diuretics, ACE inhibitors, angiotensin receptor blockers (ARBs), and NSAIDs, as these can increase serum potassium. Individuals with kidney disease or those on medications affecting potassium should only use this supplement under strict medical supervision.

Dosage

The optimal dosage for potassium bisglycinate chelate is typically extrapolated from general potassium supplementation studies, which often use 40-100 mEq (approximately 1560-3900 mg) of elemental potassium per day to achieve blood pressure-lowering effects. For bisglycinate chelate, the dose should be formulated to provide an equivalent amount of elemental potassium. The minimum effective dose for blood pressure reduction is generally considered to be at least 40 mEq/day. To improve absorption and minimize potential gastrointestinal discomfort, it is recommended to take divided doses with meals. The maximum safe daily intake of potassium from all sources (diet plus supplements) should generally not exceed 100 mEq without medical supervision, especially given the risk of hyperkalemia. The chelated form may offer better tolerance at higher doses, but individual tolerance varies. Adequate magnesium and balanced sodium intake are also important for maintaining potassium homeostasis.

FAQs

Is potassium bisglycinate chelate better absorbed than potassium chloride?

It is likely better absorbed due to the chelation with glycine, which may reduce gastrointestinal irritation and improve uptake. However, direct comparative clinical trials are limited.

Can it lower blood pressure?

Yes, potassium supplementation, including this form, can lower blood pressure, especially in hypertensive individuals. This effect is attributed to potassium's general role in cardiovascular regulation.

Is it safe for kidney disease?

No, it is not safe for individuals with kidney disease. There is a high risk of developing hyperkalemia, which can be dangerous. Medical supervision is essential.

How long does it take to see effects?

Benefits, particularly blood pressure reduction, are typically observed after 4 weeks or more of consistent supplementation.

Does it cause side effects?

It is generally well-tolerated. Gastrointestinal upset is less common than with inorganic potassium salts, but the risk of hyperkalemia exists, especially with improper use or pre-existing conditions.

Research Sources

https://www.foodstandards.gov.au/sites/default/files/publications/Documents/EU%20health%20claims%20reviews/Systematic%20Review%20Potassium%20and%20blood%20pressure.pdf – This systematic review and meta-analysis by FSANZ (2014) found that potassium supplementation significantly reduces systolic and diastolic blood pressure in hypertensive individuals, with smaller effects in normotensives. The study did not specifically investigate the bisglycinate chelate form, but its findings support the general blood pressure-lowering effects of potassium.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5013341/ – This systematic review and meta-analysis by Cappuccio et al. (2016) confirmed the blood pressure-lowering effects of potassium supplements across 23 randomized controlled trials. It also noted no serious adverse effects associated with potassium supplementation, reinforcing its safety profile. Similar to other reviews, it did not provide specific data on the bisglycinate chelate form.
https://pubmed.ncbi.nlm.nih.gov/38780173/ – A systematic review and meta-analysis by McNally et al. (2024) demonstrated that potassium supplementation lowers plasma aldosterone levels. This mechanism contributes to blood pressure regulation and provides further insight into how potassium exerts its cardiovascular benefits. The study did not specify the form of potassium used, thus not providing direct evidence for bisglycinate chelate.
https://lpi.oregonstate.edu/mic/minerals/potassium – This resource from the Linus Pauling Institute provides comprehensive information on potassium, including its role in reducing stroke risk. It highlights that higher potassium intake is associated with a reduced risk of stroke by approximately 13% when comparing high versus low intake groups. This supports the broader cardiovascular benefits of adequate potassium.